Patents by Inventor Selena HEALY

Selena HEALY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • for treating obesity and associated metabolic disorders
    Patent number: 11490643
    Abstract: The strain Lactobacillus casei AH077 (NCIMB12019) produces a polysaccharide and increases energy excretion. The strain acts to block fat absorption and is used in the prevention or treatment of obesity and obesity-related metabolic syndrome.
    Type: Grant
    Filed: March 30, 2021
    Date of Patent: November 8, 2022
    Assignee: PrecisionBiotics Group Limited
    Inventors: Barry Kiely, Eileen Frances Murphy, Selena Healy
  • LACTOBACILLUS CASEI FOR TREATING OBESITY AND ASSOCIATED METABOLIC DISORDERS
    Publication number: 20210282444
    Abstract: The strain Lactobacillus casei AH077 (NCIMB12019) produces a polysaccharide and increases energy excretion. The strain acts to block fat absorption and is used in the prevention or treatment of obesity and obesity-related metabolic syndrome.
    Type: Application
    Filed: March 30, 2021
    Publication date: September 16, 2021
    Applicant: PrecisionBiotics Group Limited
    Inventors: Barry KIELY, Eileen Frances MURPHY, Selena HEALY
  • for treating obesity and associated metabolic disorders
    Patent number: 10973862
    Abstract: Bifidobacterium longum AH1362 (NCIMB 41715) produces a polysaccharide and increases energy excretion. The strain is used in the prevention or treatment of obesity and obesity-related metabolic syndrome.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: April 13, 2021
    Assignee: PrecisionBiotics Group Limited
    Inventors: Barry Kiely, Eileen Frances Murphy, Selena Healy
  • BIFIDOBACTERIUM LONGUM FOR TREATING OBESITY AND ASSOCIATED METABOLIC DISORDERS
    Publication number: 20190111090
    Abstract: Bifidobacterium longum AH1362 (NCIMB 41715) produces a polysaccharide and increases energy excretion. The strain is used in the prevention or treatment of obesity and obesity-related metabolic syndrome.
    Type: Application
    Filed: December 9, 2016
    Publication date: April 18, 2019
    Inventors: Barry KIELY, Eileen Frances MURPHY, Selena HEALY
  • LACTOBACILLUS CASEI FOR TREATING OBESITY AND ASSOCIATED METABOLIC DISORDERS
    Publication number: 20180360092
    Abstract: The strain Lactobacillus casei AH077 (NCIMB12019) produces a polysaccharide and increases energy excretion. The strain acts to block fat absorption and is used in the prevention or treatment of obesity and obesity-related metabolic syndrome.
    Type: Application
    Filed: December 9, 2016
    Publication date: December 20, 2018
    Inventors: Barry KIELY, Eileen Frances MURPHY, Selena HEALY